[IP] CozMore - now what?
We just received our Cozmo (one week ago)...today there was the CozMor
announcement (see below). What do I have to do to get this? Return the current
purchase the new?
Want to send this story to another AOL member? Click on the heart at the top
of this window.
Deltec's New CozMore(TM) Insulin Technology System Revolutionizes Diabetes
First-ever, All-in-One Insulin Pump and Blood Glucose Meter Makes Managing
Diabetes Easier Than Ever
ST. PAUL, Minn., June 10 /PRNewswire/ -- Deltec introduces the CozMore(TM)
Insulin Technology System, the first all-in-one smart insulin pump and blood
glucose monitoring system that helps people with diabetes take charge of their
daily diabetes management. The system will be introduced at the American
Diabetes Association's 63rd Scientific Sessions, June 13-17, New Orleans
The CozMore(TM) Insulin Technology System is a collaborative effort between
Deltec, creator of the Deltec Cozmo(TM) Personal Insulin Pump, and TheraSense,
manufacturer of the FreeStyle(R) Blood Glucose Monitoring System. As the first
and only all-in-one insulin pump and blood glucose monitor, the CozMore(TM)
Insulin Technology System gives users "real-time" glucose data and insulin
delivery options in one place for quick and easy access.
"The CozMore(TM) Insulin Technology System blends two state-of-the-art
products -- The Deltec Cozmo(TM) insulin pump, the premier choice among insulin
users, and the FreeStyle(R) blood glucose monitoring system, a virtually
painless glucose testing alternative -- to create a revolution in diabetes
management," said Rod Kellogg, vice president and general manager, Deltec.
merging of great products and the resulting innovative technology promises to
lighten the cumbersome routine people with diabetes go through on a daily
By combining premier insulin pump and blood glucose testing technology,
Deltec and TheraSense have made diabetes management a more portable, hassle-
routine for more than 255,000 insulin pump users in the U.S. "As a leader in
blood glucose monitoring technology, we're constantly looking for ways to
eliminate barriers to better diabetes management and improve the quality of
for people with diabetes," said Mark Lortz, president and CEO, TheraSense.
"With the help of FreeStyle's Nano-sample(TM) technology and our advances in
test accuracy, we believe the CozMore(TM) Insulin Technology System can
significantly change the way that people manage their diabetes on a daily
CozMore(TM) System components include:
Deltec Cozmo(TM) Personal Insulin Pump -- an insulin pump with advanced
technology and easy-to-use features that helps people with diabetes more
regulate their insulin usage, increasing their health and quality of life.
CoZmonitor(TM) Blood Glucose Monitoring System -- a virtually painless blood
glucose monitoring system powered by TheraSense FreeStyle(R) technology, which
gives users accurate and precise blood glucose results with a 0.3 microliter
sample -- a blood drop about the size of a pinhead.
CoZmanager(TM) PC Communications System -- a complete software program that
links the CozMore(TM) System with a computer, allowing users to personalize the
system to their lifestyle, as well as track and review histories on more than
2,000 system "events."
How the CozMore(TM) System works:
The CozMore(TM) System is both lightweight and easy to use. First, users
lance their fingertip or a less painful, alternate testing site (the forearm,
upper arm, thigh, calf or fleshy part of the hand) with a FreeStyle(R) Lancing
device. Next, they insert the FreeStyle(R) Test Strip into the CoZmonitor(TM)
System, which is attached to the Deltec Cozmo(TM) Insulin Pump.
The CoZmonitor(TM) System automatically transfers the blood glucose
information to the Deltec Cozmo(TM) Pump through an infrared port. If the
glucose level is higher than normal, he or she can go directly to the bolus
menu to correct it without having to manually re-enter the blood glucose value,
ensuring more consistent insulin delivery.
In addition, blood glucose results are combined with insulin delivery data
and stored in the Deltec Cozmo(TM) Insulin Pump's history log to provide a
complete picture of the user's diabetes management, allowing them to be more
proactive in their insulin decisions. The system's central data storage
capabilities also allow users to go through fewer steps and therapy
reducing the risk of data or transcription errors.
Because insulin pump therapy requires more frequent blood glucose testing,
it's not unusual for a typical user to check his or her glucose levels six to
eight times a day or more. The CozMore(TM) System's small, compact size makes
it easier for pump users to carry everything necessary to manage their
diabetes, eliminating the need for them to store and/or carry around multiple
Deltec has submitted a 510(k) application to the FDA for clearance, and the
first CozMore(TM) System units are expected to be available after January 2004.
Deltec is a world leader in the design, manufacture and distribution of
medical devices used in ambulatory infusion therapy, including ambulatory
pumps, large volume infusion pumps, implantable access systems, dialysis and
infusion catheters, needles and insulin delivery systems. Headquartered in St.
Paul, Minn., Deltec is part of the medical division of Smiths Group plc,
London, and is committed to developing the highest quality, most reliable
to provide innovative, convenient and cost-effective drug delivery worldwide.
Visit us at www.deltec.com .
TheraSense develops, manufactures and sells easy-to-use glucose monitoring
systems that dramatically reduce the pain of testing for people with diabetes.
TheraSense began selling its first product, the FreeStyle(R) Blood Glucose
Monitoring System, in June 2000. The FreeStyle(R) system has wide distribution
the United States through national retailers including Walgreens, Wal-Mart,
CVS, Eckerd and Rite Aid. The TheraSense headquarters and test strip
manufacturing facility are located in Alameda, California. Visit us at
The foregoing contains statements regarding development of and development
strategy for new products and services. These statements are forward-looking
within the meaning of the Private Securities Litigation Reform Act of 1995.
statements are based on management's current expectations and actual results
could differ materially. We undertake no obligation to update or revise any
forward-looking statement. There are a number of factors that could cause
events to differ materially from those indicated by such forward- looking
statements. These factors include, but are not limited to: substantial
competition in the market for blood glucose monitoring products; risks related
failure to protect our intellectual property and litigation in which we may
involved; risks relating to development of innovative products; risks related
to noncompliance with FDA regulations; and limited manufacturing experience and
dependence on single third-party manufacturers.
CO:&nbsp; Deltec; American Diabetes Association's 63rd Scientific Sessions;
ST: Minnesota, Louisiana, California
SU: PDT TDS JVN
Web site: http://www.DeltecCozmo.com
06/10/2003 09:37 EDT
Very sincerely yours,
Ellen H. Ullman ;
Mom, Advocate for children who have diabetes and their parents, Friend,
Webmaster.. <A HREF="http://www.kidsrpumping.com/">Kids R Pumping</A>
Please support funding a cure for diabetes: Diabetes Research Institute in
Miami, Florida: <A HREF="http://www.drinet.org">http://www.drinet.org</A>
How wonderful it is that nobody need wait a single moment before starting
to improve the world? -Anne Frank, Holocaust diarist (1929-1945)
for HELP or to subscribe/unsubscribe, contact: